StonvexLoading…
StonvexStonvexStonvexCore line items from FNWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $91.76M | $89.18M | $85.78M | $72.03M |
Operating Income | $8.11M | $13.46M | $8.04M | $16.56M |
Net Income | $8.09M | $12.13M | $8.38M | $15.08M |
EPS (Diluted) | $1.88 | $2.84 | $1.96 | $3.60 |
Total Assets | $2.02B | $2.06B | $2.11B | $2.07B |
Total Liabilities | $1.85B | $1.91B | $1.96B | $1.93B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $9.05M | $6.73M | $23.06M | $14.70M |
Shares Outstanding | 4.33M | 4.31M | 4.30M | 4.30M |